Sailaja Puttagunta
Chief Tech/Sci/R&D Officer chez ITERUM THERAPEUTICS PLC
Fortune : 15 968 $ au 31/03/2024
Profil
Sailaja Puttagunta is currently the Chief Medical Officer at Iterum Therapeutics Plc.
She previously held positions as Vice President of Development & Medical Affairs at Durata Therapeutics, Vice President of Medical Affairs at Allergan Ltd., Vice President of Development at Iterum Therapeutics Plc, and Chief Medical Officer at BiomX Ltd.
and BiomX, Inc. She received her graduate degree from New York University School of Medicine and her undergraduate degree from Gandhi Medical College & Hospital.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ITERUM THERAPEUTICS PLC
0,08% | 01/12/2023 | 10 369 ( 0,08% ) | 15 968 $ | 31/03/2024 |
Postes actifs de Sailaja Puttagunta
| Sociétés | Poste | Début |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 13/12/2021 |
Anciens postes connus de Sailaja Puttagunta
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMX INC. | Chief Tech/Sci/R&D Officer | 13/12/2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2018 |
| ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/12/2014 |
Formation de Sailaja Puttagunta
| Gandhi Medical College & Hospital | Undergraduate Degree |
| New York University School of Medicine | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ITERUM THERAPEUTICS PLC | Health Technology |
| BIOMX INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
